Biotechnology Intrommune Therapeutics To Present A New Form Of Allergy Treatment At The 2024 American Academy Of Allergy, Asthma & Immunology (AAAAI) Annual Meeting Read more
Biotechnology AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue and Profit Fall – Cerevel Therapeutics Hldg (NASDAQ:CERE), AbbVie (NYSE:ABBV) Read more